Sustained Clostridium tertium Bacteremia in a Nonneutropenic Patient A Case Report and a Review of the Literature

被引：1

作者：

Nambiar, Puja H. ^{[1
]}

Belden, Katherine A. ^{[2
]}

Roslund, Brian ^{[1
]}

Silibovsky, Randi ^{[2
]}

机构：

[1] Thomas Jefferson Univ Hosp, 1015 Chestnut St,Suite 1020, Philadelphia, PA 19107 USA

[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Div Infect Dis, Philadelphia, PA 19107 USA

来源：

INFECTIOUS DISEASES IN CLINICAL PRACTICE | 2016年 / 24卷 / 04期

关键词：

C; tertium; bacteremia; malignancy; emerging pathogen;

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We report a case of sustained Clostridium tertium bacteremia mimicking an endovascular infection in a nonneutropenic patient with metastatic pancreatic neuroendocrine cancer. Clostridium tertium infection has been increasingly recognized in immunocompromised patients. The significance of this organism in nonneutropenic host, however, is unclear. The diagnosis and treatment can be challenging owing to morphology and antibiotic resistance patterns. Newer rapid identification testing with mass spectrometry enables for early diagnosis and treatment. We discuss the clinical significance of C. tertium as an emerging pathogen with review of the literature.

引用

页码：201 / 203

页数：3

共 24 条

[1]

Allen SD, 1999, MANUAL CLIN MICROBIO, P654

[2] The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: Analysis of pooled clinical trial data [J].

Babinchak, T ;

Ellis-Grosse, E ;

Dartois, N ;

Rose, GM ;

Loh, E .

CLINICAL INFECTIOUS DISEASES, 2005, 41 :S354-S367

[3] In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections [J].

Bradford, PA ;

Weaver-Sands, DT ;

Petersen, PJ .

CLINICAL INFECTIOUS DISEASES, 2005, 41 :S315-S332

[4]

BUTLER T, 1982, GASTROENTEROLOGY, V82, P133

[5]

Cato E. P., 1986, BERGEYS MANUAL SYSTE, P1141

[6] NEUTROPENIC ENTEROCOLITIS ASSOCIATED WITH CLOSTRIDIUM-TERTIUM [J].

COLEMAN, N ;

SPEIRS, G ;

KHAN, J ;

BROADBENT, V ;

WIGHT, DGD ;

WARREN, RE .

JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (02) :180-183

[7] The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Adominal Infections The European Experience [J].

Fomin, P. ;

Koalov, S. ;

Cooper, A. ;

Babinchak, T. ;

Dartois, N. ;

De Vane, N. ;

Castaing, N. ;

Tellado, J. .

JOURNAL OF CHEMOTHERAPY, 2008, 20 :12-19

[8] Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents [J].

Goldstein, Ellie J. C. ;

Citron, Diane M. ;

Merriam, C. Vreni ;

Warren, Yumi A. ;

Tyrrell, Kerin L. ;

Fernandez, Helen T. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) :3507-3513

[9] ISOLATION OF CLOSTRIDIUM IN HUMAN INFECTIONS - EVALUATION OF 114 CASES [J].

GORBACH, SL ;

THADEPALLI, H .

JOURNAL OF INFECTIOUS DISEASES, 1975, 131 :S81-S85

[10] Clostridium tertium bacteremia: 2 cases and review [J].

Gosbell, IB ;

Johnson, CG ;

Newton, PJ ;

Jelfs, J .

PATHOLOGY, 1996, 28 (01) :70-73

← 1 2 3 →